AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 13,384
-208 (-1.53%)
At close: Jan 5, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 210.77 billion as of January 5, 2026. Its market cap has increased by 32.56% in one year.
Market Cap
210.77B
Enterprise Value
229.05B
Revenue
43.24B
Ranking
n/a
PE Ratio
30.36
Stock Price
13,384.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 210.77B, an increase of 4,532.00%. That is a compound annual growth rate of 12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 207.55B | -2.94% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 73.48B |
| Haleon | 32.96B |
| Smith & Nephew | 10.35B |
| Convatec Group | 4.67B |
| Hikma Pharmaceuticals | 3.37B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.24B |